Romeo Power, Inc. (RMO, RMO.WT) Made Misstatements Regarding its Ability to Meet Demand On October 5, 2020, RMG Acquisition Corp., a special purpose acquisition company, announced a definitive agreement for
Franklin Wireless Corp. (FKWL) Failed to Disclose its Hotspot Devices Suffered from Battery Issues On April 1, 2021, Franklin stated that it “ha[d] been notified of reports of battery
Canaan Inc. (CAN) Made Misstatements Regarding its Business Metrics and Financial Prospects On February 10, 2021, Canaan issued a press release announcing that its “revenue visibility ha[d] improved substantially”
3D Systems Corp. (DDD) Lacked Proper Internal Controls Over Financial Reporting Throughout the class period, 3D Systems attested to the accuracy of its financial reporting and disclosure controls and
FibroGen, Inc. (FGEN) Misstated the Efficacy of its Drug Roxadustat On November 8, 2019, FibroGen announced positive Phase 3 pooled roxadustat safety and efficacy results, noting the “the potential
Amdocs Limited (DOX) Misstated its Financials Amdocs conducted its 2021 Annual General Meeting (“AGM”) on January 29, 2021, wherein all ten directors were elected to the Board, the quarterly
3D Systems Corp. (DDD) Lacked Proper Internal Controls Over Financial Reporting Throughout the class period, 3D Systems attested to the accuracy of its financial reporting and disclosure controls and
CytoDyn Inc. (CYDY) Misled Shareholders About the Viability of its Drug for the Treatment of COVID-19 CytoDyn is a biotech company that – prior to the COVID-19 pandemic – was
Ebang International Holdings Inc. (EBON) Misled Investors Regarding its Business Plan During the class period, Ebang failed to disclose to investors that: (i) the proceeds from Ebang’s initial public offering
Attorney Advertising. Past results do not guarantee a similar outcome.
5060 Shoreham Pl., Ste. 300 San Diego, CA 92122
Disclaimer | Site Map | Privacy Policy
© 2024 – Robbins LLP
Protect yourStock Watch members receive free investment monitoring and notifications.
